These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37724319)

  • 1. Performance Comparison Between Conventional Fluorescent Spot Test and Quantitative Assay in Detecting G6PD Deficiency in Neonates.
    Halim SA; Bahar R; Abdullah WZ; Zon EM; Yusoff SM
    Oman Med J; 2023 Jul; 38(4):e524. PubMed ID: 37724319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
    Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
    Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
    Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
    PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiquantitative screening test for G6PD deficiency detects severe deficiency but misses a substantial proportion of partially-deficient females.
    Ainoon O; Alawiyah A; Yu YH; Cheong SK; Hamidah NH; Boo NY; Zaleha M
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):405-14. PubMed ID: 12971572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of detection of glucose-6-phosphate dehydrogenase deficiency using fluorescent spot test, enzyme assay and molecular method for prediction of severe neonatal hyperbilirubinaemia.
    Wang FL; Boo NY; Ainoon O; Wong MK
    Singapore Med J; 2009 Jan; 50(1):62-7. PubMed ID: 19224086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of quantitative point-of-care test for measurement of glucose-6-phosphate dehydrogenase enzyme activity in Malaysia.
    Zailani MAH; Raja Sabudin RZA; Abdul Jalil D; Ithnin A; Ayub NA; Alauddin H; Jalil N; Md Fauzi A; Cheah FC; Lim LS; Safian N; Yusuf MM; Othman A
    Malays J Pathol; 2023 Apr; 45(1):31-41. PubMed ID: 37119244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: A cohort study.
    Thielemans L; Gornsawun G; Hanboonkunupakarn B; Paw MK; Porn P; Moo PK; Van Overmeire B; Proux S; Nosten F; McGready R; Carrara VI; Bancone G
    Wellcome Open Res; 2018; 3():1. PubMed ID: 29552643
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period.
    Keihanian F; Basirjafari S; Darbandi B; Saeidinia A; Jafroodi M; Sharafi R; Shakiba M
    Int J Lab Hematol; 2017 Jun; 39(3):251-260. PubMed ID: 28258653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification to reporting of qualitative fluorescent spot test results improves detection of glucose-6-phosphate dehydrogenase (G6PD)-deficient heterozygote female newborns.
    Nadarajan V; Shanmugam H; Sthaneshwar P; Jayaranee S; Sultan KS; Ang C; Arumugam S
    Int J Lab Hematol; 2011 Oct; 33(5):463-70. PubMed ID: 21501392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of optimal cutoff value to accurately identify glucose-6-phosphate dehydrogenase-deficient heterozygous female neonates.
    Miao JK; Chen QX; Bao LM; Huang Y; Zhang J; Wan KX; Yi J; Wang SY; Zou L; Li TY
    Clin Chim Acta; 2013 Sep; 424():131-5. PubMed ID: 23680071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninferiority of glucose-6-phosphate dehydrogenase deficiency diagnosis by a point-of-care rapid test vs the laboratory fluorescent spot test demonstrated by copper inhibition in normal human red blood cells.
    Baird JK; Dewi M; Subekti D; Elyazar I; Satyagraha AW
    Transl Res; 2015 Jun; 165(6):677-88. PubMed ID: 25312015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neonatal reticulocytosis on glucose 6-phosphate dehydrogenase (G6PD) activity and G6PD deficiency detection: a cross-sectional study.
    Pimpakan T; Mungkalasut P; Tansakul P; Chanda M; Jugnam-Ang W; Charucharana S; Cheepsunthorn P; Fucharoen S; Punnahitananda S; Cheepsunthorn CL
    BMC Pediatr; 2022 Nov; 22(1):678. PubMed ID: 36419023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for glucose-6-phosphate dehydrogenase deficiency in neonates: a comparison between cord and peripheral blood samples.
    AlSaif S; Ponferrada MB; AlKhairy K; AlTawil K; Sallam A; Ahmed I; Khawaji M; AlHathlol K; Baylon B; AlSuhaibani A; AlBalwi M
    BMC Pediatr; 2017 Jul; 17(1):159. PubMed ID: 28693459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines.
    Espino FE; Bibit JA; Sornillo JB; Tan A; von Seidlein L; Ley B
    PLoS One; 2016; 11(2):e0148172. PubMed ID: 26849445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity.
    Alam MS; Kibria MG; Jahan N; Thriemer K; Hossain MS; Douglas NM; Phru CS; Khan WA; Price RN; Ley B
    PLoS One; 2018; 13(11):e0206331. PubMed ID: 30388146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd), CareStart qualitative rapid diagnostic test performance, and genetic variants in two malaria-endemic areas in Sudan.
    Ali Albsheer MM; Lover AA; Eltom SB; Omereltinai L; Mohamed N; Muneer MS; Mohamad AO; Abdel Hamid MM
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009720. PubMed ID: 34699526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of G6PD deficiency in Thai blood donors, the characteristics of G6PD deficient blood, and the efficacy of fluorescent spot test to screen for G6PD deficiency in a hospital blood bank setting.
    Rojphoung P; Rungroung T; Siriboonrit U; Vejbaesya S; Permpikul P; Kittivorapart J
    Hematology; 2022 Dec; 27(1):208-213. PubMed ID: 35134307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization.
    Azma RZ; Hidayati N; Farisah NR; Hamidah NH; Ainoon O
    Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):982-8. PubMed ID: 21073074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the fluorescence spot test for neonatal screening of G6PD deficiency.
    Jiang J; Ma X; Song C; Lin B; Cao W; Wu S; Hsiao KJ
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():140-2. PubMed ID: 15906719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh.
    Ley B; Alam MS; O'Donnell JJ; Hossain MS; Kibria MG; Jahan N; Khan WA; Thriemer K; Chatfield MD; Price RN; Richards JS
    PLoS One; 2017; 12(1):e0169930. PubMed ID: 28121993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.